Jamie Fernandez
Psychiatry · Tampa, FLNPI 1326176736
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $299,953 of the $417,741 with a category attached, or 71.8%. Johnson & Johnson accounts for 90.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $133,642 and has fallen 98.2% since, to $2,418 in 2025. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 570 payments — averaging $732.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$377K
- Axsome Therapeutics, Inc.$12K
- AbbVie$8K
- Biogen$5K
- Neurocrine Biosciences, Inc.$4K
- Sage Therapeutics, LLC$4K
- plus $8K from 15 others
Across 303 payments — averaging $9272.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$1.5M
- Janssen Research & Development, LLC$511K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$358K
- Novartis$280K
- Neurocrine Biosciences, Inc.$64K
- AbbVie$53K
- plus $81K from 2 others
What the payments were for
- Consulting fees$53,10913%
- Speaking & faculty fees$299,95372%
- Travel & lodging$51,85212%
- Food & beverage$12,7803%
- Education$480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 428 | $376,545 |
| Axsome Therapeutics, Inc. | 10 | $12,074 |
| AbbVie | 30 | $7,705 |
| Biogen | 8 | $5,359 |
| Neurocrine Biosciences, Inc. | 33 | $4,358 |
| Sage Therapeutics, LLC | 8 | $3,890 |
| Janssen Scientific Affairs, LLC | 1 | $2,525 |
| Janssen Global Services, LLC | 1 | $2,020 |
| E.r. Squibb & Sons, L.L.C. | 16 | $1,720 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $471 |
| Otsuka America Pharmaceutical, Inc. | 12 | $355 |
| Jazz Pharmaceuticals Inc. | 2 | $220 |
| Alkermes, Inc. | 5 | $167 |
| Livanova USA, Inc. | 1 | $121 |
| Idorsia Pharmaceuticals US Inc | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Bausch Health US, LLC | 1 | $25 |
| Neuronetics, Inc. | 1 | $21 |
| GSK | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$374,390
- Auvelity$12,028
- VRAYLAR$1,736
- ZULRESSO$1,200
- CAPLYTA$374
- VNS - Symmetry$121
- ABILIFY MAINTENA$121
How this compares
$417,741 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 14 | $20,233 |
| Aripiprazole | 26 | $1,475 |
| Lamotrigine | 38 | $607 |
| Mirtazapine | 35 | $560 |
| Bupropion XlBupropion Hcl | 27 | $522 |
| Trazodone Hcl | 21 | $412 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 24 | $334 |
| Fluoxetine Hcl | 13 | $184 |
| Alprazolam | 28 | $183 |
| Zolpidem Tartrate | 25 | $177 |
| Lorazepam | 11 | $141 |
| Escitalopram Oxalate | 11 | $122 |
| Quetiapine Fumarate | 16 | $119 |
| Sertraline Hcl | 12 | $102 |
| Propranolol Hcl | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $355 | $20,23314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Tampa
- David SheehanTampa$631K
- Hardeep SinghTampa$374K
- Kenneth PagesTampa$274K
- Chetan GandhyTampa$94K
- Deborah Knudson GonzalezTampa$81K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.